Economic impact associated with the management of dermatologic adverse drug reactions (dADRs) induced by EGFR inhibitors (EGFRIs) in lung cancer
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: T. Abraham, A. Rademaker, S. Ortiz, C. L. Bennett, E. Richey, N. J. Nonzee, D. P. West, J. D. Patel, M. E. Lacouture
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589487952